State Street’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $44.9M | Buy |
|
|||||
|
2022
Q3 | $63.9M | Buy |
|
|||||
|
2022
Q2 | $79.7M | Buy |
|
|||||
|
2022
Q1 | $79.1M | Buy |
|
|||||
|
2021
Q4 | $67.9M | Buy |
|
|||||
|
2021
Q3 | $93.8M | Buy |
|
|||||
|
2021
Q2 | $99.2M | Buy |
|
|||||
|
2021
Q1 | $80.9M | Sell |
|
|||||
|
2020
Q4 | $86.5M | Buy |
|
|||||
|
2020
Q3 | $131M | Buy |
|
|||||
|
2020
Q2 | $62.7M | Buy |
|
|||||
|
2020
Q1 | $4.24M | Buy |
|
|||||
|
2019
Q4 | $7.73M | Buy |
|
|||||
|
2019
Q3 | $4.87M | Buy |
|
|||||
|
2019
Q2 | $6.07M | Buy |
|
|||||
|
2019
Q1 | $10.1M | Sell |
|
|||||
|
2018
Q4 | $14.5M | Sell |
|
|||||
|
2018
Q3 | $30.6M | Sell |
|
|||||
|
2018
Q2 | $52.1M | Buy |
|
|||||
|
2018
Q1 | $26.6M | Buy |
|
|||||
|
2017
Q4 | $79K | Buy |
|
|||||
|
2017
Q3 | $24K | Hold |
|
|||||
|
2017
Q2 | $27K | Sell |
|
|||||
|
2017
Q1 | $2.03M | Sell |
|
|||||
|
2016
Q4 | $2.52M | Buy |
|
|||||
|
2016
Q3 | $3.76M | Buy |
|
|||||
|
2016
Q2 | $2.69M | Sell |
|
|||||
|
2016
Q1 | $2.64M | Buy |
|
|||||
|
2015
Q4 | $3.8M | Buy |
|
|||||
|
2015
Q3 | $3.56M | Buy |
|
|||||
|
2015
Q2 | $5.17M | Buy |
|
|||||
|
2015
Q1 | $142K | Sell |
|
|||||
|
2014
Q4 | $128K | Buy |
|
|||||
|
2014
Q3 | $47K | Hold |
|
|||||
|
2014
Q2 | $71K | Buy |
|